Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Rushikesh M. Shukla
Observed name:
Rushikesh M. Shukla
Institution:
Zydus Lifesciences Limited (India)
Observed institution:
Zydus Lifesciences Limited (India)
ORCID:
0000-0002-7211-1207
Observed ORCID:
0000-0002-7211-1207
OpenAlex ID:
A5111360225
Selection of solvent and positive control concentration for enhanced Ames test conditions for N-nitrosamine compounds
2024
·
Chetan K. Kajavadara
, Satyam N. Patel
, et al.
·
Regulatory Toxicology and Pharmacology
·
9
Evaluating Solvent Safety in Chromosome Aberration Assays for Genetic Toxicology
2025
·
Satyam N. Patel
, Chetan K. Kajavadara
, et al.
·
Journal of Applied Toxicology
·
2
Assessing the impact of different solvents in the bacterial reverse mutation test
2025
·
Satyam N. Patel
, Chetan K. Kajavadara
, et al.
·
Environmental and Molecular Mutagenesis
·
2
PDF
Strain-specific mutagenicity of NDMA and CPNP: insights from TA1535, TA100, and WP2 uvrA (pKM101) under metabolic activation
2025
·
Chetan K. Kajavadara
, Darshan T. Valani
, et al.
·
Environmental Toxicology and Pharmacology
·
1
Comparative Analysis of TA102 and WP2 uvrA( pKM101 ) Strains in Detecting Nitrosamine Mutagens in the Enhanced Ames Test
2025
·
Rushikesh M. Shukla
, Darshan T. Valani
, et al.
·
Environmental and Molecular Mutagenesis
·
1
PDF
Show more works
View as search
Works count:
5
Citation count:
15
H-index:
2
I10-index:
Year
Topic
Type
